» Articles » PMID: 23486875

Idiopathic Normal-pressure Hydrocephalus: Pathophysiology and Diagnosis by CSF Biomarkers

Overview
Journal Neurology
Specialty Neurology
Date 2013 Mar 15
PMID 23486875
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This observational study aimed to explore the pathophysiology of idiopathic normal-pressure hydrocephalus (iNPH) and to evaluate the diagnostic and prognostic value of CSF biomarkers.

Methods: Lumbar CSF of patients with iNPH and healthy elderly individuals (HI) and ventricular CSF (VCSF) from the patients with iNPH pre and 6 months postsurgery were analyzed by ELISA. We analyzed neurofilament light protein (NFL), myelin basic protein (MBP), a panel of β-amyloid isoforms (Aβ38, Aβ40, and Aβ42), soluble amyloid precursor protein (sAPP) isoforms sAPPα and sAPPβ, total and phosphorylated tau protein (t- and p-tau), and inflammatory markers interleukin 8, interleukin 10, and monocyte chemoattractant protein 1.

Results: NFL was elevated and amyloid precursor protein (APP)-derived proteins and tau proteins were lower in patients with iNPH than in HI. Postsurgery, there was an increase of NFL, APP-derived proteins, p-tau, and albumin in VCSF, whereas levels of MBP and t-tau had decreased. Improved patients showed a greater increase of APP-derived proteins in VCSF following shunting than did those who did not improve.

Conclusions: We interpret our data as iNPH pathophysiology to be characterized by a reduced periventricular metabolism and axonal degeneration but no major cortical damage.

Citing Articles

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Thal D, Poesen K, Vandenberghe R, De Meyer S Mol Neurodegener. 2025; 20(1):33.

PMID: 40087672 DOI: 10.1186/s13024-025-00819-y.


Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Leuzy A, Bollack A, Pellegrino D, Teunissen C, La Joie R, Rabinovici G Alzheimers Dement. 2025; 21(3):e14528.

PMID: 40042435 PMC: 11881640. DOI: 10.1002/alz.14528.


Differential Lipid Signatures of Lumbar and Cisternal Cerebrospinal Fluid.

Toft-Bertelsen T, Andreassen S, Norager N, Simonsen A, Hasselbalch S, Juhler M Biomolecules. 2024; 14(11).

PMID: 39595607 PMC: 11591603. DOI: 10.3390/biom14111431.


In Vivo Prevalence of Beta-Amyloid Pathology and Alzheimer's Disease Co-Pathology in Idiopathic Normal-Pressure Hydrocephalus-Association with Neuropsychological Features.

Pyrgelis E, Paraskevas G, Constantinides V, Boufidou F, Stefanis L, Kapaki E Biomedicines. 2024; 12(8).

PMID: 39200362 PMC: 11351685. DOI: 10.3390/biomedicines12081898.


Molecular signatures of normal pressure hydrocephalus: a large-scale proteomic analysis of cerebrospinal fluid.

Kamalian A, Shirzadeh Barough S, Ho S, Albert M, Luciano M, Yasar S Fluids Barriers CNS. 2024; 21(1):64.

PMID: 39118132 PMC: 11312837. DOI: 10.1186/s12987-024-00561-5.